Skip to content

A CLINICAL TRIAL TO EVALUATE THIRD MOLAR EXTRACTION SOCKET HEALING WITH OR WITHOUT TURMERIC PLACED IN THEM

EFFICACY OF CURCUMIN (CURCUMA LONGA) AS AN ADJUVANT THERAPEUTIC AGENT AFTER SURGICAL REMOVAL OF IMPACTED MANDIBULAR THIRD MOLAR. A SPLIT MOUTH STUDY - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/066793
Enrollment
30
Registered
2024-05-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K011- Impacted teeth

Interventions

None listed

Sponsors

Dr Spoorthi T S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients aged between 18-65 years with similar impacted bilateral mandibular third molars undergoing extractions at two different intervals. 2.Patients classified under ASA I and ASA II requiring surgical extraction of similar impacted bilateral mandibular third molars 3.Selected patients will be non-smokers.

Exclusion criteria

Exclusion criteria: 1.Patients with poor oral hygiene. 2.Diseases of oral mucosa. 3.Patients with history of radiation therapy 4.Pregnant patients. 5.Patients with psychiatric illness. 6.Patients classified under ASA III and ASA IV.

Design outcomes

Primary

MeasureTime frame
1)pain assessment 2)oedema assessment 3)soft tissue healing 4)maximal interincisal openingTimepoint: 1)pain assessment on 3rd and 7th day 2)oedema assessment on 3rd and 7th day 3)soft tissue healing (3rd,7th,14th,21st days) 4)maximal interincisal opening(3rd and 7th day)

Secondary

MeasureTime frame
alveolar osteitisTimepoint: 7days

Countries

India

Contacts

Public ContactDr spoorthi

Rajarajeswari dental college and hospital

rohit.srikanthan@gmail.com9845439046

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026